A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers
2016 · Nature Communications · 157 citations
https://doi.org/10.1038/ncomms12222
E
Emilie Thomas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
210
Papers
3.5K
Citations
27
h-index
37
i10-index
Emilie Thomas is an academic researcher from Université Claude Bernard Lyon 1. The author has contributed to research in topics: Uterine Myomas and Treatments & Ovarian cancer diagnosis and treatment & Cancer Genomics and Diagnostics. The author has an h-index of 27, co-authored 179 publications.
ORCID: 0000-0002-8313-7218Papers by this author
worksANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines
2010 · British Journal of Cancer · 136 citations
https://doi.org/10.1038/sj.bjc.6605823
<scp>ZEB</scp> 1‐mediated melanoma cell plasticity enhances resistance to <scp>MAPK</scp> inhibitors
2016 · EMBO Molecular Medicine · 125 citations
https://doi.org/10.15252/emmm.201505971
Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolution
2020 · Nature Communications · 98 citations
https://doi.org/10.1038/s41467-020-17249-7
Syntenic Relationships between Genomic Profiles of Fiber-Induced Murine and Human Malignant Mesothelioma
2011 · American Journal Of Pathology · 52 citations
https://doi.org/10.1016/j.ajpath.2010.10.039
A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes
2017 · BMC Medicine · 50 citations
https://doi.org/10.1186/s12916-017-0929-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat